PROTOCOL AND STATISTICAL ANALYSIS PLAN 
 
 Study Title: REVLIMID (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and 
Follicular Thyroid Carcinoma  
Institution/Site:  University of Kentucky 
Document (Approval/Update) Date: 09-21-2008 
Study ID: [REMOVED] 
IRB Number 05-701-F3R 
Coversheet created: 05-28-2020 
 
 